Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunopathogenesis and therapy of cutaneous T cell lymphoma
E. J. Kim
Journal of Clinical Investigation (2005) Vol. 115, Iss. 4, pp. 798-812
Open Access | Times Cited: 148

Showing 1-25 of 148 citing articles:

EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome
Franz Trautinger, Robert Knobler, Rein Willemze, et al.
European Journal of Cancer (2006) Vol. 42, Iss. 8, pp. 1014-1030
Closed Access | Times Cited: 408
Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma
Madeleine Duvic, Jenny Vu
Expert Opinion on Investigational Drugs (2007) Vol. 16, Iss. 7, pp. 1111-1120
Closed Access | Times Cited: 325
The Risk of Lymphoma in Patients with Psoriasis
Joel M. Gelfand, Daniel B. Shin, Andrea L. Neimann, et al.
Journal of Investigative Dermatology (2006) Vol. 126, Iss. 10, pp. 2194-2201
Open Access | Times Cited: 306
Mycosis fungoides and Sézary syndrome
Samuel Hwang, John E. Janik, Elaine S. Jaffe, et al.
The Lancet (2008) Vol. 371, Iss. 9616, pp. 945-957
Closed Access | Times Cited: 267
Selective Induction of Apoptosis by Histone Deacetylase Inhibitor SAHA in Cutaneous T-Cell Lymphoma Cells: Relevance to Mechanism of Therapeutic Action
Chunlei Zhang, Victoria M. Richon, Xiao Ni, et al.
Journal of Investigative Dermatology (2005) Vol. 125, Iss. 5, pp. 1045-1052
Open Access | Times Cited: 245
Sézary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)
Elise A. Olsen, Alain H. Rook, John A. Zic, et al.
Journal of the American Academy of Dermatology (2010) Vol. 64, Iss. 2, pp. 352-404
Closed Access | Times Cited: 161
IL-31 Expression by Inflammatory Cells is Preferentially Elevated in Atopic Dermatitis
Günther F.L. Hofbauer, Stephan Nobbe, Piotr Dziunycz, et al.
Acta Dermato Venereologica (2012) Vol. 92, Iss. 1, pp. 24-28
Open Access | Times Cited: 149
Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?
Julia Scarisbrick, Y.H. Kim, Sean Whittaker, et al.
British Journal of Dermatology (2014) Vol. 170, Iss. 6, pp. 1226-1236
Closed Access | Times Cited: 138
Malignant inflammation in cutaneous T‐cell lymphoma—a hostile takeover
Thorbjørn Krejsgaard, Lise M. Lindahl, Nigel P. Mongan, et al.
Seminars in Immunopathology (2016) Vol. 39, Iss. 3, pp. 269-282
Open Access | Times Cited: 129
Cutaneous T-cell Lymphoma and Pruritus: The Expression of IL-31 and its Receptors in the Skin
Leigh Nattkemper, Maria Estela Martínez‐Escala, Andrew E. Gelman, et al.
Acta Dermato Venereologica (2016) Vol. 96, Iss. 7, pp. 894-898
Open Access | Times Cited: 103
Phase II Evaluation of Gemcitabine Monotherapy for Cutaneous T-Cell Lymphoma
Madeleine Duvic, Rakhshandra Talpur, Sijin Wen, et al.
Clinical Lymphoma & Myeloma (2006) Vol. 7, Iss. 1, pp. 51-58
Closed Access | Times Cited: 150
Canine cutaneous epitheliotropic T‐cell lymphoma: a review
Jacques Fontaine, C. Bovens, S. V. Bettenay, et al.
Veterinary and Comparative Oncology (2009) Vol. 7, Iss. 1, pp. 1-14
Closed Access | Times Cited: 117
Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphoma
Youn H. Kim, Michael Girardi, Madeleine Duvic, et al.
Journal of the American Academy of Dermatology (2010) Vol. 63, Iss. 6, pp. 975-983
Closed Access | Times Cited: 109
Hypopigmented mycosis fungoides: a review of its clinical features and pathophysiology
Fabricio Cecanho Furlan, José Antônio Sanches
Anais Brasileiros de Dermatologia (2013) Vol. 88, Iss. 6, pp. 954-960
Open Access | Times Cited: 78
The discovery and development of romidepsin for the treatment of T-cell lymphoma
Piotr Smolewski, Tadeusz Robak
Expert Opinion on Drug Discovery (2017), pp. 1-15
Closed Access | Times Cited: 70
Lack of Suppressive CD4+CD25+FOXP3+ T Cells in Advanced Stages of Primary Cutaneous T-Cell Lymphoma
Machteld M. Tiemessen, Tracey J. Mitchell, Lisa Hendry, et al.
Journal of Investigative Dermatology (2006) Vol. 126, Iss. 10, pp. 2217-2223
Open Access | Times Cited: 97
Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma
Sean Whittaker, Francine M. Foss
Cancer Treatment Reviews (2007) Vol. 33, Iss. 2, pp. 146-160
Open Access | Times Cited: 91
Reduction of Fas/CD95 Promoter Methylation, Upregulation of Fas Protein, and Enhancement of Sensitivity to Apoptosis in Cutaneous T-Cell Lymphoma
Jianqiang Wu, Gary S. Wood
Archives of Dermatology (2010) Vol. 147, Iss. 4, pp. 443-443
Closed Access | Times Cited: 78
The Use of Interferons in the Treatment of Cutaneous T-Cell Lymphoma
Natalie Spaccarelli, Alain H. Rook
Dermatologic Clinics (2015) Vol. 33, Iss. 4, pp. 731-745
Open Access | Times Cited: 63
Primary cutaneous lymphomas: diagnosis and treatment
Małgorzata Sokołowska‐Wojdyło, Karolina Olek‐Hrab, Katarzyna Rückemann-Dziurdzińska
Advances in Dermatology and Allergology (2015) Vol. 5, pp. 368-383
Open Access | Times Cited: 62
Bcl3 regulates pro-survival and pro-inflammatory gene expression in cutaneous T-cell lymphoma
Tzu‐Pei Chang, Ivana Vancurova
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2014) Vol. 1843, Iss. 11, pp. 2620-2630
Open Access | Times Cited: 56
Cellular Interactions and Inflammation in the Pathogenesis of Cutaneous T-Cell Lymphoma
Veronica Stolearenco, Martin R. J. Namini, Siri S. Hasselager, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 39
Increased Expression of CTLA-4 in Malignant T Cells from Patients with Mycosis Fungoides – Cutaneous T-Cell Lymphoma
Henry K. Wong, Adam J. Wilson, Heather M. Gibson, et al.
Journal of Investigative Dermatology (2005) Vol. 126, Iss. 1, pp. 212-219
Open Access | Times Cited: 84
Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins
Anders Woetmann, Paola Lovato, Karsten W. Eriksen, et al.
Blood (2006) Vol. 109, Iss. 8, pp. 3325-3332
Open Access | Times Cited: 78
A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides
Madeleine Duvic, Matthew L. Sherman, Gary S. Wood, et al.
Journal of the American Academy of Dermatology (2006) Vol. 55, Iss. 5, pp. 807-813
Closed Access | Times Cited: 68
Page 1 - Next Page

Scroll to top